Results 81 to 90 of about 105,927 (341)

Electronic health records improve the diagnosis and prognosis of pulmonary fungal infections in lung cancer patients

open access: yesVIEW, EarlyView.
Pulmonary fungal infections are life‐threatening complications in lung cancer patients, posing significant challenges in clinical management. To address this, we developed machine learning tools that translate routine electronic health record data into actionable insights for diagnosing infections and assessing prognosis.
Hongwei Meng   +14 more
wiley   +1 more source

Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study

open access: yesmedRxiv, 2020
Background: Superinfections, including invasive pulmonary aspergillosis (IPA), are well-known complications of critically ill patients with severe viral pneumonia.
T. Lahmer   +14 more
semanticscholar   +1 more source

In Vitro Activities of Five Antifungal Drugs Against Conidia and Sclerotic Cells of Chromoblastomycosis Agent Fonsecaea spp

open access: yesMicrobiology and Immunology, EarlyView.
ABSTRACT Chromoblastomycosis (CBM) is a chronic skin and subcutaneous infection mainly caused by Fonsecaea pedrosoi, a dematiaceous fungus with various morphotypes. Characteristic sclerotic cells—globe‐shaped, multiseptated and pigmented—are found in lesions of infected individuals, though their differentiation in the host remains poorly understood. To
Aline Barral Takahashi   +6 more
wiley   +1 more source

Aspergillus felis in Patient with Chronic Granulomatous Disease

open access: yesEmerging Infectious Diseases, 2019
We report a case of Aspergillus felis infection in a patient with chronic granulomatous disease who had overlapping features of invasive pulmonary aspergillosis and allergic bronchopulmonary aspergillosis.
Olivier Paccoud   +8 more
doaj   +1 more source

Asthma referrals : a key component of asthma management that needs to be addressed [PDF]

open access: yes, 2017
Peer reviewedPublisher ...
Bergen, David A   +3 more
core   +1 more source

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

open access: yesAllergy, EarlyView.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer   +12 more
wiley   +1 more source

Signalling C-Type Lectins in Antimicrobial Immunity [PDF]

open access: yes, 2013
Funding: This work was funded by the Wellcome Trust, Medical Research Council and the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Peer ...
Brown, Gordon D., Drummond, Rebecca A.
core   +6 more sources

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis. [PDF]

open access: yes, 2019
Invasive pulmonary aspergillosis (IPA) due to Aspergillus fumigatus is a serious fungal infection in the immunosuppressed patient population. Despite the introduction of new antifungal agents, mortality rates remain high, and new treatments are needed ...
Alkhazraji, Sondus   +7 more
core  

Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients [PDF]

open access: yes, 2013
Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients
Klingebiel, Thomas   +3 more
core   +2 more sources

INVASIVE ASPERGILLOSIS COMPLICATED BY STERNAL OSTEOMYELITIS [PDF]

open access: bronze, 2023
SALLY TAYEL, BRYAN RUBIO, Hary Suseelan
openalex   +1 more source

Home - About - Disclaimer - Privacy